Arcadia Biosciences (RKDA) Registration filing summary

Company overview and business model

• Focuses on science-based innovation in consumer goods, notably Zola coconut water products after acquiring Zola in 2021.

• Previously commercialized wheat products through food sales, trait licensing, and royalties.

• Recent asset sales include the RS durum wheat trait to Corteva for $4M and the Good Wheat brand to Above Food Corp. for $3.7M.

• Entered and terminated a merger agreement with Roosevelt Resources LP in 2024–2025.

• In 2025, restructured agreements with Bioceres Crop Solutions, transferring certain soy traits and patents for $750,000.

Financial performance and metrics

• Accumulated deficit, recurring net losses, and negative cash flow from operations as of December 31, 2025, and March 31, 2026.

• Substantial doubt exists about the ability to continue as a going concern without additional financing.

• Gross proceeds from the June 2026 private placement were approximately $4M; potential gross proceeds from full exercise of options could reach $7.4M.

Use of proceeds and capital allocation

• Will not receive proceeds from stockholder resales; only from cash exercise of options.

• Any proceeds from option exercises will be used for working capital and general corporate purposes.

• Management has broad discretion over use of proceeds, which may not enhance results or stock price.